Annual ROE
15.95%
-0.31%-1.91%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual return on equity is 15.95%, with the most recent change of -0.31% (-1.91%) on December 31, 2024.
- During the last 3 years, REGN annual ROE has fallen by -38.26% (-70.58%).
- REGN annual ROE is now -81.60% below its all-time high of 86.68%, reached on December 31, 2012.
Performance
REGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
15.78%
-1.41%-8.20%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly return on equity is 15.78%, with the most recent change of -1.41% (-8.20%) on December 31, 2024.
- Over the past year, REGN quarterly ROE has dropped by -0.55% (-3.37%).
- REGN quarterly ROE is now -84.71% below its all-time high of 103.18%, reached on December 31, 2012.
Performance
REGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
REGN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | -3.4% |
| 3 y3 years | -70.6% | -3.4% |
| 5 y5 years | -25.2% | -3.4% |
REGN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.6% | at low | -71.0% | +2.6% |
| 5 y | 5-year | -70.6% | at low | -71.0% | +2.6% |
| alltime | all time | -81.6% | +121.0% | -84.7% | +115.6% |
Regeneron Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 15.95%(-1.9%) | 15.78%(-8.2%) |
| Sep 2024 | - | 17.19%(+3.5%) |
| Jun 2024 | - | 16.61%(+8.0%) |
| Mar 2024 | - | 15.38%(-5.8%) |
| Dec 2023 | 16.26%(-22.3%) | 16.33%(-4.7%) |
| Sep 2023 | - | 17.13%(-10.5%) |
| Jun 2023 | - | 19.14%(-1.0%) |
| Mar 2023 | - | 19.33%(-7.8%) |
| Dec 2022 | 20.94%(-61.4%) | 20.96%(-23.4%) |
| Sep 2022 | - | 27.38%(-11.6%) |
| Jun 2022 | - | 30.99%(-35.1%) |
| Mar 2022 | - | 47.77%(-12.3%) |
| Dec 2021 | 54.21%(+70.6%) | 54.45%(+2.0%) |
| Sep 2021 | - | 53.39%(-1.4%) |
| Jun 2021 | - | 54.14%(+46.9%) |
| Mar 2021 | - | 36.86%(+12.1%) |
| Dec 2020 | 31.77%(+49.0%) | 32.88%(+10.3%) |
| Sep 2020 | - | 29.82%(+5.0%) |
| Jun 2020 | - | 28.39%(+31.9%) |
| Mar 2020 | - | 21.53%(+0.8%) |
| Dec 2019 | 21.32%(-35.0%) | 21.35%(-7.7%) |
| Sep 2019 | - | 23.14%(-3.8%) |
| Jun 2019 | - | 24.05%(-21.1%) |
| Mar 2019 | - | 30.48%(-8.9%) |
| Dec 2018 | 32.81%(+45.0%) | 33.46%(+25.9%) |
| Sep 2018 | - | 26.58%(+5.1%) |
| Jun 2018 | - | 25.28%(+3.2%) |
| Mar 2018 | - | 24.49%(+10.5%) |
| Dec 2017 | 22.63%(+2.4%) | 22.17%(-12.0%) |
| Sep 2017 | - | 25.18%(+2.1%) |
| Jun 2017 | - | 24.67%(+10.9%) |
| Mar 2017 | - | 22.24%(+1.5%) |
| Dec 2016 | 22.10%(+7.8%) | 21.91%(+6.0%) |
| Sep 2016 | - | 20.67%(+0.9%) |
| Jun 2016 | - | 20.49%(-5.9%) |
| Mar 2016 | - | 21.77%(+8.3%) |
| Dec 2015 | 20.50%(+36.5%) | 20.11%(+3.6%) |
| Sep 2015 | - | 19.42%(+20.5%) |
| Jun 2015 | - | 16.11%(+17.8%) |
| Mar 2015 | - | 13.67%(-5.9%) |
| Dec 2014 | 15.02%(-42.0%) | 14.53%(-6.3%) |
| Sep 2014 | - | 15.51%(-23.1%) |
| Jun 2014 | - | 20.18%(-7.8%) |
| Mar 2014 | - | 21.89%(-17.6%) |
| Dec 2013 | 25.88%(-70.1%) | 26.56%(-55.8%) |
| Sep 2013 | - | 60.08%(-21.4%) |
| Jun 2013 | - | 76.47%(-16.8%) |
| Mar 2013 | - | 91.90%(-10.9%) |
| Dec 2012 | 86.68%(-298.1%) | 103.18%(+156.9%) |
| Sep 2012 | - | 40.16%(-830.2%) |
| Jun 2012 | - | -5.50%(-84.1%) |
| Mar 2012 | - | -34.52%(-24.1%) |
| Dec 2011 | -43.76%(+93.6%) | -45.48%(+14.4%) |
| Sep 2011 | - | -39.76%(+15.5%) |
| Jun 2011 | - | -34.42%(+26.2%) |
| Mar 2011 | - | -27.28%(+6.0%) |
| Dec 2010 | -22.60%(+36.3%) | -25.73%(-21.6%) |
| Sep 2010 | - | -32.82%(+39.5%) |
| Jun 2010 | - | -23.53%(+14.9%) |
| Mar 2010 | - | -20.47%(+24.4%) |
| Dec 2009 | -16.58%(-7.6%) | -16.45%(+16.7%) |
| Sep 2009 | - | -14.10%(-24.3%) |
| Jun 2009 | - | -18.63%(-2.3%) |
| Mar 2009 | - | -19.06%(+7.1%) |
| Dec 2008 | -17.95%(-42.5%) | -17.79%(+8.1%) |
| Sep 2008 | - | -16.45%(-29.3%) |
| Jun 2008 | - | -23.26%(-22.8%) |
| Mar 2008 | - | -30.14%(-31.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | -31.20%(-49.6%) | -43.84%(-42.7%) |
| Sep 2007 | - | -76.56%(-1.7%) |
| Jun 2007 | - | -77.87%(-7.9%) |
| Mar 2007 | - | -84.51%(-4.3%) |
| Dec 2006 | -61.91%(-3.8%) | -88.35%(-12.7%) |
| Sep 2006 | - | -101.25%(+12.5%) |
| Jun 2006 | - | -90.00%(+13.4%) |
| Mar 2006 | - | -79.39%(+30.4%) |
| Dec 2005 | -64.37%(-347.1%) | -60.89%(+64.1%) |
| Sep 2005 | - | -37.11%(+70.0%) |
| Jun 2005 | - | -21.83%(+52.4%) |
| Mar 2005 | - | -14.32%(-161.4%) |
| Dec 2004 | 26.05%(-134.4%) | 23.34%(+107.3%) |
| Sep 2004 | - | 11.26%(+480.4%) |
| Jun 2004 | - | 1.94%(-124.7%) |
| Mar 2004 | - | -7.86%(-89.1%) |
| Dec 2003 | -75.78%(+25.6%) | -72.14%(-8.2%) |
| Sep 2003 | - | -78.56%(+2.7%) |
| Jun 2003 | - | -76.47%(+12.4%) |
| Mar 2003 | - | -68.06%(+14.8%) |
| Dec 2002 | -60.33%(+77.6%) | -59.30%(+21.3%) |
| Sep 2002 | - | -48.87%(+24.8%) |
| Jun 2002 | - | -39.16%(+27.4%) |
| Mar 2002 | - | -30.73%(+11.4%) |
| Dec 2001 | -33.97%(+113.4%) | -27.58%(+28.0%) |
| Sep 2001 | - | -21.54%(+29.6%) |
| Jun 2001 | - | -16.62%(+18.5%) |
| Mar 2001 | - | -14.03%(-1.4%) |
| Dec 2000 | -15.92%(-17.0%) | -14.23%(+34.1%) |
| Sep 2000 | - | -10.61%(-20.5%) |
| Jun 2000 | - | -13.35%(-29.6%) |
| Mar 2000 | - | -18.97%(-2.7%) |
| Dec 1999 | -19.19%(+201.3%) | -19.49%(-11.2%) |
| Sep 1999 | - | -21.95%(+19.9%) |
| Jun 1999 | - | -18.30%(+77.5%) |
| Mar 1999 | - | -10.31%(+63.1%) |
| Dec 1998 | -6.37%(-32.5%) | -6.32%(+234.4%) |
| Sep 1998 | - | -1.89%(-16.0%) |
| Jun 1998 | - | -2.25%(-69.1%) |
| Mar 1998 | - | -7.27%(-21.7%) |
| Dec 1997 | -9.44%(-74.5%) | -9.28%(-45.8%) |
| Sep 1997 | - | -17.11%(-28.9%) |
| Jun 1997 | - | -24.08%(-23.1%) |
| Mar 1997 | - | -31.31%(-12.3%) |
| Dec 1996 | -37.07%(+6.5%) | -35.69%(-11.1%) |
| Sep 1996 | - | -40.13%(-5.9%) |
| Jun 1996 | - | -42.65%(-3.6%) |
| Mar 1996 | - | -44.25%(+17.2%) |
| Dec 1995 | -34.81%(-6.2%) | -37.76%(+11.0%) |
| Sep 1995 | - | -34.01%(+25.6%) |
| Jun 1995 | - | -27.08%(-17.9%) |
| Mar 1995 | - | -32.97%(-13.7%) |
| Dec 1994 | -37.10%(-13.7%) | -38.22%(-6.6%) |
| Sep 1994 | - | -40.94%(-14.2%) |
| Jun 1994 | - | -47.71%(+2.2%) |
| Mar 1994 | - | -46.67%(+3.6%) |
| Dec 1993 | -43.00%(+117.7%) | -45.03%(+13.4%) |
| Sep 1993 | - | -39.70%(+9.5%) |
| Jun 1993 | - | -36.25%(+32.6%) |
| Mar 1993 | - | -27.34%(+39.3%) |
| Dec 1992 | -19.75%(+159.9%) | -19.62%(+34.4%) |
| Sep 1992 | - | -14.60%(+53.7%) |
| Jun 1992 | - | -9.50%(+26.3%) |
| Mar 1992 | - | -7.52%(+43.5%) |
| Dec 1991 | -7.60%(-71.9%) | -5.24%(+25.4%) |
| Sep 1991 | - | -4.18%(-18.0%) |
| Jun 1991 | - | -5.10%(-82.7%) |
| Mar 1991 | - | -29.51%(+9.1%) |
| Dec 1990 | -27.05% | -27.05% |
FAQ
- What is Regeneron Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual ROE year-on-year change?
- What is Regeneron Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly ROE year-on-year change?
What is Regeneron Pharmaceuticals annual return on equity?
The current annual ROE of REGN is 15.95%
What is the all time high annual ROE for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual return on equity is 86.68%
What is Regeneron Pharmaceuticals annual ROE year-on-year change?
Over the past year, REGN annual return on equity has changed by -0.31% (-1.91%)
What is Regeneron Pharmaceuticals quarterly return on equity?
The current quarterly ROE of REGN is 15.78%
What is the all time high quarterly ROE for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly return on equity is 103.18%
What is Regeneron Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, REGN quarterly return on equity has changed by -0.55% (-3.37%)